Related Experiment Video

Updated: May 10, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

Current mRNA-based vaccine strategies for glioma treatment

Mengqian Mao1, Wanchun Yang1, Xuefeng Zhang2

  • 1Neuroscience & Metabolism Research, Department of Neurosurgery, West China Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.

Critical Reviews in Oncology/Hematology
|August 3, 2024
PubMed

Insights

Messenger RNA (mRNA)-based vaccines show promise for treating aggressive brain tumors called gliomas. This review highlights advances in mRNA dendritic cell vaccines, offering new hope for improved patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Gliomas are aggressive brain tumors with poor prognoses.
  • Conventional treatments like surgery, radiation, and chemotherapy have limited efficacy.
  • Novel therapeutic strategies are urgently needed to improve patient survival rates.

Purpose of the Study:

  • To review the current progress of mRNA-based vaccines for glioma treatment.
  • To focus on recent advancements in dendritic cell-based mRNA vaccines for gliomas.
  • To discuss the feasibility and safety of mRNA clinical applications in glioma therapy.

Main Methods:

  • Review of preclinical and clinical trial data on mRNA vaccines for gliomas.
  • Focus on dendritic cell (DC) based mRNA vaccine strategies.
  • Analysis of immune response modulation by mRNA vaccines.

Main Results:

  • mRNA-based vaccines, particularly dendritic cell vaccines, demonstrate significant potential in preclinical and clinical studies.
  • Dendritic cells are key in initiating anti-tumor immune responses.
  • mRNA technology offers a promising platform for glioma immunotherapy.

Conclusions:

  • mRNA-based vaccines, especially those utilizing dendritic cells, represent a promising therapeutic avenue for gliomas.
  • Further research and clinical trials are warranted to establish safety and efficacy.
  • mRNA vaccines could revolutionize glioma treatment paradigms.
Keywords:
Dendritic cellsGlioma/glioblastomaImmunotherapyVaccinemRNA

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.9K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.